1. Home
  2. ANNX vs ALCO Comparison

ANNX vs ALCO Comparison

Compare ANNX & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.53

Market Cap

334.1M

Sector

Health Care

ML Signal

HOLD

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$37.03

Market Cap

267.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
ALCO
Founded
2011
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.1M
267.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ANNX
ALCO
Price
$4.53
$37.03
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$16.60
N/A
AVG Volume (30 Days)
3.2M
24.6K
Earning Date
11-10-2025
11-24-2025
Dividend Yield
N/A
0.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$44,066,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$24.76
52 Week High
$5.66
$37.50

Technical Indicators

Market Signals
Indicator
ANNX
ALCO
Relative Strength Index (RSI) 65.87 73.89
Support Level $4.01 $31.42
Resistance Level $4.64 $32.25
Average True Range (ATR) 0.37 0.89
MACD 0.05 0.62
Stochastic Oscillator 76.03 98.71

Price Performance

Historical Comparison
ANNX
ALCO

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: